Law Offices of Howard G. Smith announces an investigation on behalf of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDLINE INDUSTRIES, INC. (MDLN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Happened?
On June 2, 2026, the FDA published a warning letter addressed to Medline regarding “significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals,” stating that, among other things, Medline “failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications.”
On this news, Medline’s stock price fell $2.56, or 7.16%, to close at $33.19 per share on June 2, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Medline securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260609775945/en/
Media gallery
